Integrum
7.93 SEK
-2.10 %
Less than 1K followers
INTEG B
First North Stockholm
Medical Equipment & Services
Health Care
Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Valuation
Income statement
Quarter data
Income statement
Financial statements, revenue, EBIT, valuation metrics, and quarterly estimates for Integrum
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| Revenue | 22.4 | 26.7 | 43.1 | 55.7 | 74.3 | 104.1 | 91.1 |
| growth-% | 19.1 % | 61.1 % | 29.3 % | 33.3 % | 40.2 % | -12.5 % | |
| EBITDA | -24.0 | -15.1 | 0.3 | 2.3 | -18.6 | 8.7 | -35.8 |
| EBIT | -24.6 | -15.7 | -0.3 | 1.0 | -19.7 | 6.5 | -42.4 |
| Profit before taxes | -24.6 | -15.7 | -0.6 | 1.2 | -21.5 | 6.0 | -42.5 |
| Net income | -24.6 | -15.7 | -0.6 | 21.3 | -3.7 | 4.2 | -30.9 |
| EPS | -1.94 | -1.03 | -0.04 | 1.17 | -0.20 | 0.23 | -1.43 |
| Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend ratio | -0.0 % | -0.0 % | -0.0 % | 0.0 % | -0.0 % | 0.0 % | -0.0 % |
Profitability and return on capital
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|
| EBITDA-% | -107.1 % | -56.5 % | 0.6 % | 4.1 % | -25.0 % | 8.3 % | -39.3 % |
| EBIT-% | -109.5 % | -58.6 % | -0.7 % | 1.9 % | -26.5 % | 6.3 % | -46.5 % |
| ROE | -153.2 % | -72.2 % | -2.3 % | 13.3 % | -2.6 % | 2.9 % | -17.3 % |
| ROI | -98.7 % | -51.9 % | -1.6 % | 11.8 % | -2.3 % | 2.5 % | -15.2 % |